Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy

Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy / Sonpavde, G., Pond, G.r., Rosenberg, J.e., Choueiri, T.k., Bellmunt, J., Regazzi, A.m., Mullane, S.a., Necchi, A., Raggi, D., Lee, J.l., Lee, S., Simpson, J., Derleth, C.l., Lin, S.w., Bajorin, D.f.. - In: CLINICAL GENITOURINARY CANCER. - ISSN 1558-7673. - 16:4(2018), pp. E961-E967. [10.1016/j.clgc.2018.03.016]